A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

To determine the recommended dose of endoscopically assisted high-dose-rate intraluminal brachytherapy (HDR-192Ir-ILBT) as a palliative treatment of extrahepatic biliary tract cancer.
Original languageEnglish
Pages (from-to)401-404
Number of pages4
JournalBrachytherapy
Volume14
DOIs
Publication statusPublished - 2015

Keywords

  • Aged
  • Aged, 80 and over
  • Bile Duct Neoplasms
  • Bile Ducts, Extrahepatic
  • Brachytherapy
  • Colangiocarcinoma
  • Endoscopy
  • Female
  • Humans
  • Iridium Radioisotopes
  • Male
  • Metal stents
  • Middle Aged
  • Neoplasm
  • Palliative Care
  • Prospective Studies
  • Radiotherapy Dosage
  • Survival Rate

Fingerprint Dive into the research topics of 'A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer'. Together they form a unique fingerprint.

Cite this